EUVIMEDEUVIMED entdecken
Crossref

Prostein (p501s) is expressed in primary extramammary Paget disease

Daniel J Shepherd iD, Cody Craig iD, Aida L Valencia-Guerrero, Sairam Chattu iD, Roshan Bhattarai iD, Leonel F Maldonado iD, Jennifer B Gordetsky iD

Histopathology · 2026

DOI: 10.1111/his.70076 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Histopathology, 2026. Verfasst von Daniel J Shepherd und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA. Hauptthemen laut MEDLINE: Paget Disease, Extramammary, Biomarkers, Tumor, Skin Neoplasms. Die Arbeit nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Extramammary Paget disease (EMPD) is an intraepidermal carcinoma that typically involves the urogenital, perineal and perianal skin. EMPD is classified as primary if arising directly in the skin, or secondary if spreading from another malignancy, most commonly urothelial carcinoma and colorectal adenocarcinoma. Prostein (p501s) immunoreactivity was initially described as sensitive and specific for prostatic epithelial cells including prostatic adenocarcinoma. Herein, we investigated the expression of prostein in primary EMPD of the external genitalia, secondary EMPD involving the external genitalia or perineum, and mammary Paget disease (MPD). Methods and Results Prostein was negative by immunohistochemistry in all cases of MPD ( n = 0/11) and secondary EMPD ( n = 0/5). Conversely, prostein was positive in all cases of primary EMPD ( n = 11/11), including non‐invasive and invasive components and including one nodal metastasis. Among these cases, 5/11 (45%) showed non‐focal moderate‐to‐strong staining, 3/11 (27%) showed focal weak staining, and 3/11 (27%) cases showed weak diffuse staining. All cases of primary EMPD additionally showed diffuse 2–3+ staining for GATA3, and 10/11 cases of primary EMPD showed diffuse 2–3+ staining for androgen receptor (AR).

Conclusions

These findings suggest that prostein may be a promising immunohistochemical marker for the diagnosis of primary EMPD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Paget Disease, ExtramammaryBiomarkers, TumorSkin NeoplasmsHumansMaleImmunohistochemistryFemaleAgedAged, 80 and overMiddle AgedPaget's Disease, MammaryGenital Neoplasms, MaleMembrane Transport Proteins

Substanzen

Biomarkers, TumorPIP protein, humanMembrane Transport Proteins

Autor:innen und Institutionen

  • Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Department of Urology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

ORCID-Profile: Daniel J Shepherd, Cody Craig, Sairam Chattu, Roshan Bhattarai, Leonel F Maldonado, Jennifer B Gordetsky

Zitieren

APA

Shepherd, D. J., Craig, C., Valencia-Guerrero, A. L., Chattu, S., Bhattarai, R., Maldonado, L. F., & Gordetsky, J. B. (2026). Prostein (p501s) is expressed in primary extramammary Paget disease. Histopathology. https://doi.org/10.1111/his.70076

Vancouver

Shepherd DJ, Craig C, Valencia-Guerrero AL, Chattu S, Bhattarai R, Maldonado LF, et al. Prostein (p501s) is expressed in primary extramammary Paget disease. Histopathology. 2026. doi:10.1111/his.70076

BibTeX
@article{Shepherd2026,
  author = {Shepherd, Daniel J and Craig, Cody and Valencia-Guerrero, Aida L and Chattu, Sairam and Bhattarai, Roshan and Maldonado, Leonel F and Gordetsky, Jennifer B},
  title = {Prostein (p501s) is expressed in primary extramammary Paget disease},
  journal = {Histopathology},
  year = {2026},
  doi = {10.1111/his.70076}
}
Kostenlos starten →